425 related articles for article (PubMed ID: 27378567)
1. Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide.
Zhou Z; Martin E; Sharina I; Esposito I; Szabo C; Bucci M; Cirino G; Papapetropoulos A
Pharmacol Res; 2016 Sep; 111():556-562. PubMed ID: 27378567
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.
Rahaman MM; Nguyen AT; Miller MP; Hahn SA; Sparacino-Watkins C; Jobbagy S; Carew NT; Cantu-Medellin N; Wood KC; Baty CJ; Schopfer FJ; Kelley EE; Gladwin MT; Martin E; Straub AC
Circ Res; 2017 Jul; 121(2):137-148. PubMed ID: 28584062
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous hydrogen sulfide in nerve-evoked relaxation of pig terminal bronchioles.
Fernandes VS; Recio P; López-Oliva E; Martínez MP; Ribeiro AS; Barahona MV; Martínez AC; Benedito S; Agis-Torres Á; Cabañero A; Muñoz GM; García-Sacristán A; Orensanz LM; Hernández M
Pulm Pharmacol Ther; 2016 Dec; 41():1-10. PubMed ID: 27603231
[TBL] [Abstract][Full Text] [Related]
4. BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex.
Dai Y; Stuehr DJ
Mol Pharmacol; 2023 May; 103(5):286-296. PubMed ID: 36868790
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness of rat aorta and pulmonary artery to cGMP generators in the presence of thiol or heme oxidant.
Tawa M; Yamashita Y; Masuoka T; Nakano K; Yoshida J; Nishio M; Ishibashi T
J Pharmacol Sci; 2019 May; 140(1):43-47. PubMed ID: 31036520
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE
Olivencia MA; Esposito E; Brancaleone V; Castaldo S; Cirino G; Pérez-Vizcaino F; Sorrentino R; d'Emmanuele di Villa Bianca R; Mitidieri E
Pharmacol Res; 2023 Aug; 194():106834. PubMed ID: 37343646
[TBL] [Abstract][Full Text] [Related]
7. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
Wang WZ; Jones AW; Wang M; Durante W; Korthuis RJ
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H521-32. PubMed ID: 23771693
[TBL] [Abstract][Full Text] [Related]
12. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
[TBL] [Abstract][Full Text] [Related]
13. Targeting heme-oxidized soluble guanylate cyclase to promote osteoblast function.
Tesfamariam B
Drug Discov Today; 2020 Feb; 25(2):422-429. PubMed ID: 31846712
[TBL] [Abstract][Full Text] [Related]
14. Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation.
Durgin BG; Hahn SA; Schmidt HM; Miller MP; Hafeez N; Mathar I; Freitag D; Sandner P; Straub AC
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31487266
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation.
Smimmo M; Casale V; Casillo GM; Mitidieri E; d'Emmanuele di Villa Bianca R; Bello I; Schettino A; Montanaro R; Brancaleone V; Indolfi C; Cirino G; Di Lorenzo A; Bucci M; Panza E; Vellecco V
Biomed Pharmacother; 2024 May; 174():116466. PubMed ID: 38552439
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydrogen peroxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
Free Radic Res; 2015; 49(12):1479-87. PubMed ID: 26334090
[TBL] [Abstract][Full Text] [Related]
17. Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.
Zhou Z; Pyriochou A; Kotanidou A; Dalkas G; van Eickels M; Spyroulias G; Roussos C; Papapetropoulos A
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1763-71. PubMed ID: 18757489
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I
Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050
[TBL] [Abstract][Full Text] [Related]
19. BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugs.
Sömmer A; Sandner P; Behrends S
Biochem Pharmacol; 2018 Jan; 147():10-20. PubMed ID: 29155144
[TBL] [Abstract][Full Text] [Related]
20. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
